Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Recruiting

Phase 2

TulisokibartStudy to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Sponsor:

Merck Sharp & Dohme LLC

Code:

NCT07486960

Conditions

Psoriatic Arthritis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Tulisokibart

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-14. This information was provided to ClinicalTrials.gov by Merck Sharp & Dohme LLC on 2026-05-04.